M&A Deal Summary

Brooklyn ImmunoTherapeutics Acquires IRX Therapeutics

On November 7, 2018, Brooklyn ImmunoTherapeutics acquired life science company IRX Therapeutics

Acquisition Highlights
  • This is Brooklyn ImmunoTherapeutics’ 1st transaction in the Life Science sector.
  • This is Brooklyn ImmunoTherapeutics’ 1st transaction in the United States.
  • This is Brooklyn ImmunoTherapeutics’ 1st transaction in New York.

M&A Deal Summary
Date 2018-11-07
Target IRX Therapeutics
Sector Life Science
Buyer(s) Brooklyn ImmunoTherapeutics
Deal Type Add-on Acquisition

Target

IRX Therapeutics

New York, New York, United States
IRX Therapeutics is a clinical-stage company developing novel immunotherapies focused on reducing the immune suppression that is seen in the cancer tumor microenvironment, restoring immune function, and activating a coordinated immune response against the tumor. The lead candidate, IRX-2, is a proprietary therapeutic containing numerous active cytokine components. Data collected to date indicates that IRX-2 acts to restore and activate multiple immune cell types, including T cells, dendritic cells, and natural killer cells to recognize and destroy tumors.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Brooklyn ImmunoTherapeutics

Brooklyn, New York, United States
Category Company
Sector Life Science
DESCRIPTION

Brooklyn ImmunoTherapeutics is focused on providing cytokine-based therapy to treat patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Its most advanced program is studying the safety and efficacy of IRX-2 in patients with head and neck cancer. In a Phase 2A clinical trial in head and neck cancer, IRX-2 demonstrated an overall survival benefit. Additional studies are either underway or planned in other solid tumor cancer indications. Brooklyn ImmunoTherapeutics is based in Brooklyn, New York.

DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 1
State (New York) 1 of 1
Country (United States) 1 of 3
Year (2018) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-08-13 Buzztime

Carlsbad, California, United States

Buzztime delivers interactive entertainment and innovative technology that helps its customers acquire, engage, and retain their patrons. The company's tablets, mobile app, and technology offer engaging solutions to establishments that have guests who experience dwell time, such as in bars, restaurants, casinos, and senior living centers. Buzztime was founded in 1983 and is based in Carlsbad, California.

Buy -
Mergr

Product

Company

Legal